The international guidelines for diagnosing multiple sclerosis (MS), called the McDonald criteria, underwent their most significant overhaul in a decade in 2024. The internationally recognized framework is used to diagnose MS by combining clinical, imaging and laboratory findings. Dr. Jiwon Oh, director of the BARLO MS Centre at St. Michael’s Hospital, was among the experts who helped write them.
Now, in a commentary published in Nature Medicine, Oh has brought together nearly 30 of the world’s leading MS clinicians to critically evaluate what those changes mean and where the field must go next to improve health outcomes for people with MS. Many of its co-authors also helped develop the revised criteria in 2024.
“This commentary looks critically at the new criteria and explains why these changes matter, what challenges may arise as they’re used, and what can be done to address them,” explains Oh. “It also takes a broader look at where the field needs to go next.”








